Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Pathol Oncol Res ; 19(3): 553-8, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23539294

RESUMO

Human Papillomavirus (HPV) is the main cause of cervical cancer and its precursor lesions. Transformation may be induced by several mechanisms, including oncogene activation and genome instability. Individual differences in DNA damage recognition and repair have been hypothesized to influence cervical cancer risk. The aim of this study was to evaluate whether the double strand break gene polymorphisms XRCC2 R188H G>A (rs3218536), XRCC3 T241M C>T (rs861539) and R243H G>A (rs77381814) are associated to cervical cancer in Argentine women. A case control study consisting of 322 samples (205 cases and 117 controls) was carried out. HPV DNA detection was performed by PCR and genotyping of positive samples by EIA (enzyme immunoassay). XRCC2 and 3 polymorphisms were determined by pyrosequencing. The HPV-adjusted odds ratio (OR) of XRCC2 188 GG/AG genotypes was OR = 2.4 (CI = 1.1-4.9, p = 0.02) for cervical cancer. In contrast, there was no increased risk for cervical cancer with XRCC3 241 TT/CC genotypes (OR = 0.48; CI = 0.2-1; p = 0.1) or XRCC3 241 CT/CC (OR = 0.87; CI = 0.52-1.4; p = 0.6). Regarding XRCC3 R243H, the G allele was almost fixed in the population studied. In conclusion, although the sample size was modest, the present data indicate a statistical association between cervical cancer and XRCC2 R188H polymorphism. Future studies are needed to confirm these findings.


Assuntos
Proteínas de Ligação a DNA/genética , Neoplasias do Colo do Útero/genética , Alphapapillomavirus/genética , Alphapapillomavirus/isolamento & purificação , Estudos de Casos e Controles , DNA Viral/isolamento & purificação , Feminino , Predisposição Genética para Doença , Genótipo , Humanos , Modelos Logísticos , Razão de Chances , Infecções por Papillomavirus/genética , Infecções por Papillomavirus/patologia , Infecções por Papillomavirus/virologia , Reação em Cadeia da Polimerase , Polimorfismo de Nucleotídeo Único , Neoplasias do Colo do Útero/virologia
2.
Tumour Biol ; 33(5): 1549-56, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22592655

RESUMO

Although the implication of genetic factors in cervical cancer development remains to be elucidated, accumulative epidemiological evidence suggests that polymorphisms of cytokine genes may be involved in the etiology of cervical carcinoma. Tumor necrosis factor alpha (TNF-α) and interleukin-10 (IL-10) are two multifunctional cytokines implicated in inflammation, immunity, and cellular organization, and were proposed to play important roles in cancer biology. In order to determine whether IL-10 -1082 (G/A) and TNF-α -238 (G/A) and -308 (G/A) polymorphisms are associated with susceptibility to cervical cancer, a case-control study of 122 cancer patients and 176 healthy controls was conducted. Cervical samples were genotyped for both TNF-α polymorphisms by PCR-RFLP assay. SNP-1082 from IL-10 gene was genotyped using pyrosequencing technology. The association between cervical cancer risk and the studied SNPs was evaluated by logistic regression. Under univariate analysis, none of these polymorphisms appeared associated with susceptibility of cervical cancer development or HPV infection. However, individuals carrying heterozygous genotype for TNF-α -238 polymorphism seem to be at lower risk for cervical cancer development, with borderline significance (OR = 0.42, P = 0.069), as well as those carrying heterozygous genotypes for IL-10 and TNF-α -238 (OR = 0.40, P = 0.08). In conclusion, these results suggest a potential effect of TNF-α -238 G/A in the reduction of cervical cancer risk in Argentine women, but not TNF-α -308 or IL-10. Larger studies are needed to fully understand the genetic predisposition for the development of cervical cancer.


Assuntos
Interleucina-10/genética , Infecções por Papillomavirus/complicações , Polimorfismo de Nucleotídeo Único , Regiões Promotoras Genéticas , Fator de Necrose Tumoral alfa/genética , Neoplasias do Colo do Útero/genética , Neoplasias do Colo do Útero/virologia , Adulto , Alelos , Estudos de Casos e Controles , Feminino , Frequência do Gene , Genótipo , Humanos , Pessoa de Meia-Idade , Papillomaviridae/classificação , Papillomaviridae/genética , Infecções por Papillomavirus/virologia , Risco , Neoplasias do Colo do Útero/etiologia
3.
Cancer Genet ; 204(5): 270-7, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21665181

RESUMO

Epidemiological evidence suggests that genetic factors, such as variants in cancer suppressor genes, may play an important role in the etiology of cervical carcinoma. TP53 is an outstanding cell cycle regulator, mutated in most human cancers, and RNASEL is thought to be involved in antiviral and apoptotic responses. To determine whether TP53 Arg72Pro and RNASEL Arg462Gln polymorphisms are associated with susceptibility to cervical cancer, a case-control study of 98 cancer patients and 123 healthy controls was conducted. Cervical samples were genotyped for both polymorphisms by pyrosequencing technology. The association between cervical cancer risk and the studied SNPs was evaluated by logistic regression, and potential gene-gene interactions were studied by Multifactor Dimensionality Reduction analysis. In the single-locus analysis, only the heterozygous TP53 Arg72Pro genotype was significantly associated with the risk of developing a cervical carcinoma, while the RNASEL polymorphism showed no association after age adjustment. In addition, the combination of both polymorphisms gives near-null information gain. Consequently, the effect provided by each single nucleotide polymorphism individually is considered higher than the effect resulting from the interaction between these two genes in cervical cancer risk. These results suggest that a heterozygous TP53 Arg72Pro genotype may contribute to cervical cancer susceptibility.


Assuntos
Endorribonucleases/genética , Polimorfismo Genético , Proteína Supressora de Tumor p53/genética , Neoplasias do Colo do Útero/genética , Argentina , Códon/genética , Feminino , Genótipo , Humanos , Fatores de Risco
4.
Pathol Oncol Res ; 16(3): 461-8, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20232185

RESUMO

The aim of the present study is to determine the presence and molecular integrity of high-risk HPV types in colorectal adenocarcinomas and to assess whether viral DNA is related to common proto-oncogene alterations, such as k-ras mutations and c-myc gene amplification, in colorectal cancer. Seventy-five colorectal adenocarcinomas were screened for HPV infection using nested-PCR (MY09/11-GP5+/6+). HPV typing was performed by type-specific PCR for HPV 16 and HPV 18 DNA. Unidentified samples were subsequently sequenced to determine the viral genotype. The physical status of HPV was determined by a nested PCR approach for type-specific E2 sequences. C-myc amplification was assessed by co-amplification with ß-globin as control locus, and mutation in k-ras codons 12 and 13 by ARMS-PCR. Overall, HPV was detected in thirty-three colorectal specimens (44%). HPV 16 was the prevalent type (16/75), followed by HPV 18 (15/75), HPV 31 (1/75) and HPV 66 (1/75). E2 disruption was detected in 56.3% of HPV 16 and in 40% of HPV 18 positive tumors. C-myc amplification was detected in 29.4% of cases, while k-ras mutations in 30.7%. There was no significant trend for HPV infection in tumors harboring either k-ras or c-myc alterations. This study demonstrates HPV DNA and viral integration in colorectal tumors, suggesting a potential role of this virus in colorectal carcinogenesis. There was no concurrence, however, of k-ras and c-myc activation with viral infection.


Assuntos
Adenocarcinoma/genética , Adenocarcinoma/virologia , Neoplasias Colorretais/genética , Neoplasias Colorretais/virologia , Infecções por Papillomavirus/genética , DNA Viral/análise , DNA Viral/genética , Feminino , Amplificação de Genes , Genes myc , Genes ras , Humanos , Masculino , Pessoa de Meia-Idade , Mutação , Oncogenes , Papillomaviridae/genética , Reação em Cadeia da Polimerase , Proto-Oncogene Mas , Integração Viral/genética
6.
World J Gastroenterol ; 12(9): 1426-9, 2006 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-16552814

RESUMO

AIM: To evaluate the potential association between p53 codon 72 polymorphism and sporadic colorectal adenocarcinoma development,and human papillomavirus (HPV) infection. METHODS: One-hundred and nine controls and 53 patients with colon cancer from the city of La Plata, Argentina were analyzed. p53 codon 72 genotypes and HPV infection were identified using allele-specific polymerase chain reaction and nested polymerase chain reaction, respectively. RESULTS: The differences in the distribution of p53 codon 72 polymorphism between the cases and controls were statistically significant. The arginine allele had a prevalence of 0.65 in controls and 0.77 in cases. The corresponding odds ratio for the homozygous arginine genotype was 2.08 (95% CI, 1.06-4.05; P<0.05). Lack of association was found between p53 polymorphism and HPV infection in the set of adenocarcinomas. CONCLUSION: The findings of the present study indicate that p53 codon 72 arginine homozygous genotype may represent a genetic predisposing factor for colon cancer development. However,further studies are needed in order to elucidate the role of p53 codon 72 polymorphism in colorectal cancer.


Assuntos
Adenocarcinoma/genética , Códon/genética , Neoplasias Colorretais/genética , Genes p53 , Polimorfismo Genético , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Argentina , Estudos de Casos e Controles , Causalidade , Predisposição Genética para Doença , Humanos , Pessoa de Meia-Idade , Papillomaviridae , Infecções por Papillomavirus/genética , Reação em Cadeia da Polimerase
7.
Int J Toxicol ; 25(1): 49-55, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16510357

RESUMO

Several studies have shown that polycyclic aromatic hydrocarbons (PAHs) produce genotoxic effects in assays performed in vivo and in vitro. This study was undertaken to investigate the ability of benzo[a]pyrene (BP) and dibenzo[a,l]pyrene (DBP) to induce DNA damage in a human lung fibroblast cell line (MRC-5), using sister-chromatid exchanges test (SCEs), the comet assay, and evaluating point mutations in codon 12 of the K-ras protooncogene by polymerase chain reaction-single-strand conformation polymorphisms (PCR-SSCPs) and restriction fragment length polymorphisms (RFLP)-enriched PCR methods. Sister-chromatid exchanges frequencies were significantly increased in cells exposed to benzo[a]pyrene and dibenzo[a,l]pyrene in relation to controls (p < .001). Using the standard alkaline comet assay, significant differences between groups were found for the variable comet moment (CM) when cells were exposed to BP (p < .001) and DBP (p < .001). Nevertheless, PCR-SSCP and RFLP-enriched PCR methods did not show any association between treatments with BP and DBP and K-ras point mutations. The data presented in this study indicated that BP and DBP induced both DNA strand breaks and sister-chromatid exchanges but not significant point mutations at codon 12 of K-ras gene in the MRC-5 cell line.


Assuntos
Benzo(a)pireno/toxicidade , Benzopirenos/toxicidade , Dano ao DNA , DNA/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Mutagênicos/toxicidade , Linhagem Celular , Ensaio Cometa , Fibroblastos/patologia , Regulação da Expressão Gênica/efeitos dos fármacos , Genes ras/efeitos dos fármacos , Genes ras/genética , Humanos , Pulmão/citologia , Mutação Puntual/efeitos dos fármacos , Polimorfismo de Fragmento de Restrição , Polimorfismo Conformacional de Fita Simples , Troca de Cromátide Irmã/efeitos dos fármacos
8.
Toxicol In Vitro ; 20(3): 279-85, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16143491

RESUMO

Based on in vitro studies, several modes of action for arsenic have been suggested, although the mechanisms responsible for arsenic carcinogenesis have not been well established. In our previous study a dose-dependent increment in DNA migration was detected at low doses of sodium arsenite, but at higher dose levels a reduction in the migration was observed, suggesting the induction of DNA adducts. In order to confirm this hypothesis we performed the experiments considering other parameters and modifications of the standard alkaline comet assay. Additionally, the induction of sister chromatid exchanges was evaluated. The present study showed the induction by sodium arsenite of single strand breaks and DNA-protein adducts assessed by comet assay as well as of sister chromatid exchanges in the human lung fibroblast cell line MRC-5. The standard alkaline comet assay also revealed, at the highest arsenic concentration tested, a reduction in all the considered parameters in relation to untreated cells and the other doses. On the other hand, the incubation with proteinase K induced a dose-dependent increment in DNA migration as a consequence of the release of proteins joined to the DNA. Thus, sodium arsenite was able to induce both DNA-strand breaks and protein-DNA adducts in arsenic exposed MRC-5 cells, depending on the concentrations of arsenic salts tested.


Assuntos
Arsenitos/toxicidade , Dano ao DNA/efeitos dos fármacos , DNA/efeitos dos fármacos , Pulmão/citologia , Mutagênicos , Troca de Cromátide Irmã/efeitos dos fármacos , Linhagem Celular , Ensaio Cometa , DNA/química , Adutos de DNA/efeitos dos fármacos , Endopeptidase K/toxicidade , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Fibroblastos/ultraestrutura , Humanos
9.
Int J Gynecol Pathol ; 25(1): 42-7, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16306783

RESUMO

The aim of the present study was to determine that prevalence of herpes simplex virus (HSV) type 1 and 2 in cervical samples from Argentine women and to assess the role of HSV-2 in cervical cancer. A sample of 79 normal and 200 neoplastic cervical tissues (35 invasive cervical carcinomas, 75 high-grade squamous intraepithelial lesions, 79 low-grade squamous intraepithelial lesions and 11 abnormal squamous cells of undermined significance) was analyzed for herpes simplex and human papillomavirus DNA using the polymerase chain reaction method. Viral genotyping was performed by single strand conformation polymorphisms and restriction fragment length polymorphisms. The overall prevalence of HSV was 21.5% in controls and 29% in cases. Among women with normal cytology, herpes simplex prevalence in HPV positive (20.8%) women was approximately the same as in negative (21.8%) women. HPV- and age- adjusted ORs of high-grade squamous intraepithelial lesions and invasive cervical carcinomas for HSV-2 were 1.4 (p = 0.6) and 1.6 (p = 0.5), respectively. The obtained results indicated that herpes simplex virus may not be involved in cervical cancer development. Future investigations are needed to provided conclusive evidence on the role of this pathogen in cervical cancer.


Assuntos
Herpes Simples/virologia , Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/virologia , Simplexvirus/isolamento & purificação , Displasia do Colo do Útero/virologia , Neoplasias do Colo do Útero/virologia , Adolescente , Adulto , Idoso , Argentina/epidemiologia , DNA Viral/análise , Feminino , Herpes Simples/patologia , Humanos , Pessoa de Meia-Idade , Papillomaviridae/genética , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/patologia , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Prevalência , Simplexvirus/genética , Neoplasias do Colo do Útero/epidemiologia , Neoplasias do Colo do Útero/patologia , Displasia do Colo do Útero/epidemiologia , Displasia do Colo do Útero/patologia
10.
Mutat Res ; 581(1-2): 83-90, 2005 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-15725607

RESUMO

Biotransformation of inorganic arsenic to form both methylarsinic acid (MA) and dimethylarsinic acid (DMA) has traditionally been considered as a mechanism to facilitate the detoxification and excretion of arsenic. However, the methylation of inorganic arsenic as a detoxification mechanism has been questioned due to recent studies revealing an important role of organic arsenic in the induction of genetic damage. In a previous report a reduction of DNA migration after treatment of cells with DMA was described. In order to further evaluate the possible induction of protein-DNA adducts, an experiment was performed taking into account other parameters and modifications of the standard alkaline comet assay. In addition, the results obtained with the comet assay were compared with those obtained by analyzing the induction of sister chromatid exchanges (SCEs). SCE frequencies were significantly increased in treated cells in relation to controls (p<0.001). Furthermore, in the standard alkaline comet assay, as well as in the control assay for proteinase K treatment, a significant dose-dependent reduction in tail moment was observed. Nevertheless, the post-treatment with proteinase K induced the release of proteins joined to the DNA and consequently, a dose-dependent increment in DNA migration was observed (p<0.001). These results suggest that DNA-protein cross-links may be an important genotoxic effect induced by dimethylarsinic acid in human MRC-5 cells.


Assuntos
Ácido Cacodílico/farmacologia , DNA , Fibroblastos/efeitos dos fármacos , Herbicidas/farmacologia , Proteínas/metabolismo , Troca de Cromátide Irmã , Animais , Células Cultivadas , Ensaio Cometa , DNA/efeitos dos fármacos , DNA/metabolismo , Fibroblastos/citologia , Fibroblastos/fisiologia , Humanos
11.
Mutat Res ; 568(2): 221-31, 2004 Dec 21.
Artigo em Inglês | MEDLINE | ID: mdl-15542109

RESUMO

Cadmium (Cd) is a toxic heavy metal of continuing occupational and environmental concern with a wide variety of adverse effects. Several studies have shown that cadmium produces DNA strand breaks, DNA-protein cross-links, oxidative DNA damage, chromosomal aberrations, dysregulation of gene expression resulting in enhanced proliferation, depressed apoptosis and/or altered DNA repair. This study was undertaken to investigate the ability of cadmium chloride (CdCl(2)) and cadmium sulphate (CdSO(4)) to induce point mutations in codon 12 of the K-ras protooncogene assessed by polymerase chain reaction-single strand conformation polymorphisms (PCR-SSCP) and RFLP-enriched PCR methods. Also their genotoxic effects were analyzed by the comet assay and sister chromatid exchanges test. The human lung fibroblast cell line MRC-5 was used for the experiments. Sister chromatid exchanges assay (SCEs) frequencies were significantly increased in cells exposed to cadmium salts in relation to controls (p<0.001). Despite the slow increment observed in the three comet parameters considered when cells were treated with cadmium chloride, significant differences between groups were only found in the variable comet moment (CM) (p<0.005). On the other hand, when cells were exposed to cadmium sulphate, the Kruskal-Wallis test showed highly significant differences between groups for migration, tail moment and comet moment parameters (p<0.001). Nevertheless, a null or weak point mutation induction in K-ras protooncogene was detected using polymerase chain reaction-low ionic strength-single strand conformation polymorphisms (PCR-LIS-SSCP) and RFLP-enriched PCR methods when cells were treated with cadmium salts. Thus, inorganic cadmium produces genotoxicity in human lung fibroblast MRC-5 cells, in the absence of significant point mutation of the K-ras gene.


Assuntos
Cloreto de Cádmio/toxicidade , Compostos de Cádmio/toxicidade , Dano ao DNA , Genes ras/genética , Mutação Puntual/genética , Sulfatos/toxicidade , Linhagem Celular , Ensaio Cometa , Genes ras/efeitos dos fármacos , Humanos , Polimorfismo de Fragmento de Restrição , Polimorfismo Conformacional de Fita Simples , Troca de Cromátide Irmã/efeitos dos fármacos , Estatísticas não Paramétricas
12.
Invest. clín ; Invest. clín;40(4): 257-66, dic. 1999. ilus
Artigo em Espanhol | LILACS | ID: lil-261528

RESUMO

Se estudiaron 91 muestras no cancerosas de citilogía exfoliativa cérvico-vaginal positivas para VPH 16 ó 18 y 27 muestras negativas como grupo control. Se analizó la prevalencia de las mutaciones en el codón 12 del gen K-ras utilizando la técnica del PCR con enriquecimiento alélico. Se encontró que el 17,58 por ciento de las muestras estudiadas presentaban mutaciones en ese codón. Se encontraron diferencias significativas entre la frecuencia de mutación en las muestras positivas para VPH y el grupo control (p<0,01). Por otra parte, no se encontraron diferencias significativas en la prevalencia de mutaciones en el gen K-ras entre ambos tipos de VPH. La presencia de mutaciones en el gen K-ras en muestras citologícas no cancerosas abre un nuevo interrogante sobre el papel de las mutaciones en proto-oncogenes y el desarrollo del cáncer cervical


Assuntos
Humanos , Feminino , Adolescente , Adulto , Biologia Celular , Displasia do Colo do Útero , Neoplasias dos Genitais Femininos , Mulheres
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA